Eli Lilly and Company will invest up to $250 million in its long-standing collaboration with Purdue University over the next eight years. This partnership, which has the potential to be the largest ever industry-academic agreement of its kind in the United States, will seek to accelerate innovation at every stage of the pharmaceutical pipeline. The Lilly-Purdue 360 Initiative aims to achieve several key goals, including: Discovering and accelerating the delivery of medicines to patients ...